BiotechTube
Home/Flashpoint Therapeutics/Michelle Teplensky, PhD
MT

Michelle Teplensky, PhD

Scientific Founder

Flashpoint Therapeutics

Therapeutic Areas

OncologyGenetic DiseasesNeurological Disorders

Flashpoint Therapeutics Pipeline

DrugIndicationPhase
Cancer Immunotherapy NanotherapeuticOncology (unspecified)Phase 1
Platform-derived NanotherapeuticsMultiple (Genetic, Neurological, etc.)Pre-clinical

Leadership Team at Flashpoint Therapeutics

BL
Barry Labinger
Chief Executive Officer
VK
Venkat Krishnamurthy, PhD
Chief Scientific Officer
ER
Eric Rowinsky, MD
Consulting Chief Medical Officer
CM
Chad Mirkin, PhD
Scientific Founder
View full Flashpoint Therapeutics profile